Skip to content
October 07, 2022

Equity.Guru

Investment information for the new generation

PTE

PolarityTE (PTE.Q) has provided an update regarding correspondence from the U.S. Food and Drug Administration (FDA) related to the Company’s Investigational New Drug Application (IND) for SkinTE®, which was…